• Article

Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK

Citation

Wolowacz, S., Roskell, N., Kelly, S., Maciver, FM., & Brand, CS. (2007). Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK. PharmacoEconomics, 25(10), 863-879.